Evaluating Buoyancy Activated Cell Sorting for T Cell Isolation in CAR-T Manufacturing

As the CAR T and TCR landscape evolves, robust manufacturing solutions that enable increased access to these transformative therapies through reduced cost and complexity must be developed. An alternative cell separation strategy that may improve manufacturability of these therapies is the isolation of T cells by negative selection using BACS.  ElevateBio’s ISCT 2025 poster evaluates the feasibility of Akadeum’s BACS technology and characterizes the performance of T cells.